Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brian Culley Insider Profile
4 Followers
Brian Culley, CEO and Director, Director at Savara, holds 154.84K shares in Lineage Therap (Ticker: LCTX), holds 34.50K shares in Savara (Ticker: SVRA). Most recently, Brian Culley Bought ― shares of Lineage Therap on May 28, 2024 for an estimated value of 10.50K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-4.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brian Culley holds in companies
Most Profitable Insider Trade
The most profitable trade made by Brian Culley
Brian Culley's Trading History
Savara
Mar 15, 2012
CEO and Director, Director
Informative Buy
12.10K
$139.03K
Lineage Therap
May 28, 2024
President & CEO, Director
Informative Buy
10.50K
$154.38K
List of latest transactions for each holding click on a transaction to see Brian Culley's performance on stock
You May Also Like
Brian Culley insider profile FAQ
What is the percentage of profitable transactions made by Brian Culley?
The percentage of profitable transactions made by Brian Culley is 25%.
What is the average return per transaction made by Brian Culley?
The average return per transaction made by Brian Culley is -4.40%.
What stocks does Brian Culley hold?
Brian Culley holds: SVRA, LCTX stocks.
What was Brian Culley’s latest transaction?
Brian Culley latest transaction was an Informative Buy of $10.50K.
What was Brian Culley's most profitable transaction?
Brian Culley’s most profitable transaction was an Informative Buy of LCTX stock on May 28, 2024. The return on the trade was 1.70%.
What is Brian Culley's role in Savara?
Brian Culley's role in Savara is CEO and Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.